Lakefront Biotherapeutics NV - ADR
:GLPG 4:00:00 PM EDT
Galapagos NV - ADR Stock, :GLPG
Industriepark Mechelen Noord, Generaal de Wittelaan L11 A3, Mechelen, Brussels Region 2800
Belgium
Phone: +32.1.534.29.00
Number of Employees: 1123
Description
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.